Screening of rodent pharmacokinetics for lead optimization
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $62,300
Award facts
- Contract value 100% obligated
- $62,300.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- St Charles, MO, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Funding Only Action | -$71,200 | |
| Original award | $133,500 |
About this award
The National Institute of Allergy and Infectious Diseases issued a $62,300 delivery order to Eurofins Discovery Services North America, LLC on July 14, 2021, under the Nonclinical Services for Development of Interventional Agents IDIQ for screening of rodent pharmacokinetics in support of lead optimization.
Place of performance is St. Charles, MO. The order carried an ultimate completion date of July 14, 2022. Work was priced on a firm fixed-price basis. The delivery order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability of those fiscal year funds.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 14, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $62,300 on 75N93021F00002.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award